Recent advances in biotechnology have brought dramatic transformations in the society. These transformations have been remarkable in the field of molecular biology and genetics, where biotechnology has opened new vistas for medicine and healthcare. The completion of the Human Genome Project has unravelled some mysteries of human life, reshaping our understanding of human genetics. With the increasing understanding of the genetic basis of human diseases through modern techniques such as diagnostic genetic testing, biotechnology has shown its potential to transform the basic framework of clinical medicine from one of ‘diagnosis and treatment’ to one of ‘prediction and prevention’. Modern techniques in biotechnology promise the new era of ‘personalized medicines’ with more accurate results as compared to traditional medicines. These scientific advances create commercial possibilities for industries. It started in 1970s with the introduction of new biological techniques such as recombinant DNA technology, genetic engineering and cell culture which led to the emergence of the biotechnology industry. The enormous potential of biotechnological advances to produce commercial results has led to the conjunction of biotechnology and intellectual property rights (IPR), where industries and intellectual property developers seek to grab new biotechnological inventions through intellectual property protection.


Intellectual Property Intellectual Property Right Intellectual Property Protection Gene Patent World Intellectual Property Organization 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Allison Malorye (2009) Diagnostic firms face new patent claim worries. Nature Biotechnology 27: 586CrossRefGoogle Scholar
  2. Andrew F. Christie (2006) A Legal Perspective. In: Bosworth Derek & Webster Elizabeth (2006) The Management of Intellectual Property. Edward Elgar Publishing Inc., MassachusettsGoogle Scholar
  3. Bud Robert (1991) Biotechnology in twentieth century. Social Studies of Science 21: 444–445CrossRefGoogle Scholar
  4. Chawala H. S. (2005) Patenting of biological Material and Biotechnology. Journal of Intellectual Property Rights 10: 44Google Scholar
  5. Duffy John F. (2002) Harmony and Diversity in Global Patent Law. Berkeley Technology Law Journal 7: 685–726 Accesses 9 May 2012Google Scholar
  6. Dutfield Graham (2006) DNA patenting: implications for public health research. Bulletin of World Health Organisation 84: 389Google Scholar
  7. Gopalan Raghuvaran (2009) Bioinformatics: Scope of Intellectual Property Protection. Journal of Intellectual Property Rights 14: 48Google Scholar
  8. Heller Michael A. and Eisenberg Rebecca S. (1998) Can Patents Deter Innovation? The Anticommons in Biomedical Research. Science 280: 698CrossRefGoogle Scholar
  9. Holyoak Jon & Torremans Paul (2005) Intellectual Property Rights. Oxford University Press, New York p. 11Google Scholar
  10. Jones Bryn Williams (2002) History of Gene Patents: Tracing the Development and Application of Commercial BRCA Testing. Health Law Journal 10: 133Google Scholar
  11. National Centre for Biotechnology Information (2011) Definition of Bioinformatics. Accessed 16 December 2011
  12. Noorzad Hazarat (2000) Biotechnology: its evolution, application, and environmental implications. Accessed 12 May 2011
  13. Paradise Jordan (2004) European opposition to exclusive control over predictive breast cancer testing and the inherent implications for U.S. patent law and public policy: a case study of the Myriad genetics BRCA Patent Controversy. Food and drug law journal 59: 147Google Scholar
  14. Peter Drahos (1999) The universality of intellectual property rights: origin and development Accessed 30 May 2011
  15. Silverstein Tina, Joly Yann, Harmsen E. et al (2009) The commercialisation of genomic academic research: conflicting trend In: E. Richard Gold & Bartha Maria Knoppers (eds.) Biotechnology IP & Ethics LexisNexis Canada Inc., Markham, Ontario, p. 133Google Scholar
  16. Smith Carrie P. (2000) Patenting Life: The potential and the pitfalls of using the WTO to globalize intellectual property rights. North Carolina Journal of International Law and Commercial Regulation 26: 143. Accessed 18 May 2008Google Scholar
  17. Statistical definition of biotechnology (2005). Accessed 16 June 2011
  18. United Nations Conference on Trade and Development (2002) Key issues in biotechnology. Accessed 12 May 2011
  19. World Health Organization (2002) Genomics and World Health, Report of the Advisory Committee on Health Research 142 Accessed 15 June 2011
  20. World Health Organization (2005) Genetics, genomics and the patenting of DNA-Review of potential implications for health in developing countries. Accessed 20 May 2011
  21. Zimmern R.L. (1999) The human genome project: a false dawn? British Medical Journal 319:1282CrossRefGoogle Scholar

Copyright information

© Springer India 2015

Authors and Affiliations

  1. 1.Amity Law SchoolNoidaIndia

Personalised recommendations